"Comment on 'international consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists'".

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Pharmacotherapy Pub Date : 2024-02-01 DOI:10.1002/phar.2906

Carlos Augusto Espinoza Cobeñas

引用次数: 0

对 "由美国临床药学院 (ACCP)、英国抗菌化疗学会 (BSAC)、囊性纤维化基金会 (CFF)、欧洲临床微生物学和传染病学会 (ESCMID)、美国传染病学会 (IDSA)、重症医学学会 (SCCM) 和传染病药剂师学会批准的关于使用长期输注 β-内酰胺类药物的国际共识建议 "发表评论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy 医学-药学

CiteScore

7.80

自引率

2.40%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The Editors and Editorial Board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.